APUS
Apimeds Pharmaceuticals US, Inc
1W: +2.3%
1M: +33.6%
3M: +4.2%
YTD: +4.8%
$1.75
+0.04 (+2.34%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$22.0M
52W Range0.951-4.031
Volume61,175
Avg Volume170,185
Beta3.71
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOVinod Menon
Employees2
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2025-05-09
Websiteapimedsus.com
2 East Broad Street
Hopewell, NJ 08525
US
Hopewell, NJ 08525
US
808-209-7887
About Apimeds Pharmaceuticals US, Inc
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.
Latest News
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
12 Health Care Stocks Moving In Tuesday's After-Market Session
Why Urgent.ly Shares Are Trading Higher By Around 159%; Here Are 20 Stocks Moving Premarket
Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Weintraub Bennett | A-Award | 10,000 | $2.67 | 2025-11-11 |
| Yoon Hankil | A-Award | 10,000 | $2.67 | 2025-11-11 |
| Koo Jakap | A-Award | 10,000 | $2.67 | 2025-11-11 |
| O'DONNELL CAROL A | A-Award | 10,000 | $2.67 | 2025-11-11 |
| Kogan Elona | A-Award | 10,000 | $2.67 | 2025-11-11 |